Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol in healthy men
NCT02718378Phase 1Completed
- Sponsor
- Pantarhei Oncology
- Start
- Mar 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of estetrol in prostatic neoplasms, sponsored by Pantarhei Oncology. Started Mar 2016; status: completed.
02
Drugs
estetrol
03
Conditions
prostatic neoplasms
Beyond the preview
Go deeper on NCT02718378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02718378.